Scott Young | Vice President, Corporate Communications and Investor Relations |
Michael Clayman | Chief Executive Officer |
Melissa Layman | Chief Commercial Officer |
Fred Driscoll | Chief Financial Officer |
Michael Pagliari | Raymond James |
Madhu Kumar | Goldman Sachs |
Daniel Busby | RBC Capital Markets |
Evan Hua | BMO Capital Markets |
Serge Belanger | Needham & Company |
Patrick Trucchio | H.C. Wainwright |
Daniel Brennan | Oppenheimer |
Good afternoon, ladies and gentlemen and welcome to the Flexion Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session at the end of today's call. [Operator Instructions] I'll now turn the call over to Scott Young, Flexion Vice President of Corporate Communications and Investor Relations.
Good afternoon.